Heidi Hagen
CIK 1585084 · Interim CEO · last filed 2026-05-01
Heidi Hagen is an Interim CEO who has filed 23 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for VCEL, was dated May 1, 2026. Across all open-market trades the lifetime net is −$890.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.31M
3
23
-$890.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCEL | Director | 35,050 | $37.46 | $1.31M | -$931.9K | 18 | 2026-05-01 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Interim CEO | 145,889 | $0.87 | $126.3K | $41.8K | 4 | 2021-09-03 |
| Vericel Corp (ASTM) Delisted | Director | — | — | — | $0 | 1 | 2013-08-27 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | VCEL | Mixed | +3,200 | $0 | EDGAR |
| 2026-03-25 | VCEL | Mixed | — | -$444.7K | EDGAR |
| 2025-05-02 | VCEL | Mixed | +3,200 | $0 | EDGAR |
| 2025-03-05 | VCEL | Mixed | — | -$412.1K | EDGAR |
| 2024-10-21 | VCEL | Exer (M) | +10,000 | $37.4K | EDGAR |
| 2024-05-03 | VCEL | Mixed | +3,200 | $0 | EDGAR |
| 2023-05-05 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | VCEL | Exer (M) | +2,600 | $0 | EDGAR |
| 2022-04-29 | VCEL | Mixed | +2,600 | $0 | EDGAR |
| 2021-09-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Buy (P) | +23,770 | $41.8K | EDGAR |